Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter

RegulatoryBrevital® Sodium 500 mg/vialNegative

AI Analysis

Summary

Par Health issued a voluntary nationwide recall of two lots of Brevital® Sodium (Methohexital Sodium for Injection) due to the presence of cellulose particulate matter. The recall extends to the hospital level.

Outcome Details

Voluntary nationwide recall of two lots due to presence of particulate matter (cellulose)

Importance:5/10

Sentiment:

-0.80

product recallquality issueparticulate matterregulatorysafety

Related Companies

$HIT

Read the original article

Published by PR Newswire Biotech on October 8, 2026 10:00 PM

Read Original